Viral vector-mediated expressions of venom peptides as novel gene therapy for anxiety and depression


Por: Okada M., Ortiz E.

Publicada: 1 ene 2022
Categoría: Medicine (miscellaneous)

Resumen:
The venoms of arachnids, cone snails, and snakes consist of many peptides that have various physiological activities, e.g., modulation of ion channels. We have recently prepared lentiviral vectors that express spider venom peptides and observed their successful expression and secretion by the transduced cells themselves. We expect that this expression method can be applied to mental disorders as a new type of gene therapy. Since most psychiatric symptoms are caused by dysregulations of neuronal activities and/or synaptic transmission, a single injection of a viral vector that expresses venom peptides would modulate ion channels in the brain and thereby compensate for the dysregulations, resulting in long-lasting therapeutic potential. Here, we discuss the details of the application methods and which venom peptide would exert therapeutic effect for anxiety and depression and how. © 2022

Filiaciones:
Okada M.:
 College of Life Science, Kurashiki University of Science and the Arts, Okayama, Kurashiki, Japan

Ortiz E.:
 Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Morelos, Cuernavaca, 62210, Mexico
ISSN: 03069877
Editorial
Churchill Livingstone, JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND, Reino Unido
Tipo de documento: Article
Volumen: 166 Número:
Páginas:
WOS Id: 000828697100001
imagen hybrid, Hybrid Gold